Rema Raman - Concepedia

Author

Rema Raman

University of California San Diego ORCID

Also Known As

Adrienne Kormos, Alzheimer's Disease Cooperative Study Group, Brett C Meyer, Gloria Chiang, Ian Jones, Michael Donohue, Michael Rafii, Nicole Phillips, Paul Aisen, R Raman

411

Publications

21.6K

Citations

H-Index

183

Concepts

All Affiliations

University of California San Diego University of Southern California Harvard University Brigham and Women's Hospital Autism Research Institute

About

Rema Raman is an author at University of California San Diego specializing in medicine, neurology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	43	3.6K
2	Health Sciences	14	15	1.8K
3	Public Health	12	13	359
4	Engineering	2	2	72
5	Education	1	1	45

Rema Raman

174

Publications

17.6K

Citations

H-Index

Page 1

	Year	Citations
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, New England Journal of Medicine	2014	1.6K
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease Gorazd B. Stokin, Concepción Lillo, Tomás L. Falzone, Science Axonal DefectsNeurochemical BiomarkersCytoskeletonAlzheimer's DiseaseProtein Misfolding	2005	1.2K
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease Rachelle S. Doody, Rema Raman, Martin R. Farlow, New England Journal of Medicine	2013	1.2K
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease Joseph F. Quinn, Rema Raman, Ronald G. Thomas, JAMA	2010	736
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, Neurology	2015	671
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia Miia Kivipelto, Francesca Mangialasche, Heather M. Snyder, Alzheimer s & Dementia	2020	487
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia Suzanne Craft, Rema Raman, Tiffany W. Chow, JAMA Neurology	2020	339
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L) Thomas Hemmen, Rema Raman, Kama Z. Guluma, Stroke	2010	332
Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease Adam Fleisher, Rema Raman, Eric Siemers, Archives of Neurology	2008	331
Trial of Solanezumab in Preclinical Alzheimer’s Disease Reisa A. Sperling, Michael Donohue, Rema Raman, New England Journal of Medicine	2023	321

Page 1